Temat: "Cisplatin" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Histamine deficiency exacerbates cisplatin-induced ferroptosis in cochlea hair cells of HDC knockout mice.
Autorzy:: Wu D; Department of Otorhinolaryngology Head and Neck Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Zhu B; School of Health and Life Sciences, University of Health and Rehabilitation Sciences, Shandong 266071, China.
Yang X; Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital & Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Sun D; Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital & Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Zhu J; Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital & Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Jiang K; Department of Otorhinolaryngology Head and Neck Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Shen N; Department of Otorhinolaryngology Head and Neck Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China. Electronic address: .
Yang X; Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital & Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China. Electronic address: yangxiangdong_.
Huang X; Department of Otorhinolaryngology Head and Neck Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China. Electronic address: .; Pokaż więcej
Źródło:: International immunopharmacology [Int Immunopharmacol] 2024 Sep 10; Vol. 138, pp. 112639. Date of Electronic Publication: 2024 Jul 06.
Typ publikacji:: Journal Article
MeSH Terms:: Cisplatin*
Histidine Decarboxylase*/genetics
Histidine Decarboxylase*/metabolism
Histamine*/metabolism
Hair Cells, Auditory*/drug effects
Hair Cells, Auditory*/pathology
Hair Cells, Auditory*/metabolism
Mice, Knockout*
Ferroptosis*/drug effects
Signal Transduction*/drug effects
Animals ; Mice ; Ototoxicity ; Receptors, Histamine H1/metabolism ; Receptors, Histamine H1/genetics ; Antineoplastic Agents/adverse effects ; Mice, Inbred C57BL ; Cell Line ; Male ; NF-E2-Related Factor 2/metabolism ; NF-E2-Related Factor 2/genetics

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 2.

Tytuł:: The caspase-inhibitor Emricasan efficiently counteracts cisplatin- and neomycin-induced cytotoxicity in cochlear cells.
Autorzy:: Nassauer L; Institute of Experimental Hematology, Hannover Medical School, Carl-Neuberg-Strasse 1, D-30625, Hannover, Germany.
Schott JW; Institute of Experimental Hematology, Hannover Medical School, Carl-Neuberg-Strasse 1, D-30625, Hannover, Germany.
Harre J; Department of Otorhinolaryngology, Head and Neck Surgery, Hannover Medical School, 30625, Hannover, Germany.; Cluster of Excellence 'Hearing4all', Hannover Medical School, 30625, Hannover, Germany.
Warnecke A; Department of Otorhinolaryngology, Head and Neck Surgery, Hannover Medical School, 30625, Hannover, Germany.; Cluster of Excellence 'Hearing4all', Hannover Medical School, 30625, Hannover, Germany.
Morgan M; Institute of Experimental Hematology, Hannover Medical School, Carl-Neuberg-Strasse 1, D-30625, Hannover, Germany.
Galla M; Institute of Experimental Hematology, Hannover Medical School, Carl-Neuberg-Strasse 1, D-30625, Hannover, Germany. .
Schambach A; Institute of Experimental Hematology, Hannover Medical School, Carl-Neuberg-Strasse 1, D-30625, Hannover, Germany. .; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA. .; Pokaż więcej
Źródło:: Journal of molecular medicine (Berlin, Germany) [J Mol Med (Berl)] 2024 Sep; Vol. 102 (9), pp. 1163-1174. Date of Electronic Publication: 2024 Aug 07.
Typ publikacji:: Journal Article
MeSH Terms:: Cisplatin*/adverse effects
Cisplatin*/toxicity
Cisplatin*/pharmacology
Neomycin*/pharmacology
Neomycin*/toxicity
Caspase Inhibitors*/pharmacology
Animals ; Mice ; Apoptosis/drug effects ; Cochlea/drug effects ; Cochlea/cytology ; Cell Survival/drug effects ; Hair Cells, Auditory/drug effects ; Spiral Ganglion/drug effects ; Ototoxicity/etiology ; Ototoxicity/prevention & control ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/toxicity ; Cell Line ; Cells, Cultured

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 3.

Tytuł:: Mangiferin alleviates cisplatin-induced ototoxicity in sensorineural hearing loss.
Autorzy:: Lu X; Department of Otorhinolaryngology, Peking University Shenzhen Hospital, Shenzhen 518036, China.
Yin N; Department of Otorhinolaryngology, Peking University Shenzhen Hospital, Shenzhen 518036, China.
Chen C; Department of Otorhinolaryngology, Shenzhen Children's Hospital, Shenzhen 518034, China.
Zhou Y; Department of Otorhinolaryngology, Peking University Shenzhen Hospital, Shenzhen 518036, China.
Ji L; Department of Otorhinolaryngology, Peking University Shenzhen Hospital, Shenzhen 518036, China.
Zhang B; Department of Otolaryngology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen 518035, China. Electronic address: .
Hu H; Department of Otorhinolaryngology, Peking University Shenzhen Hospital, Shenzhen 518036, China. Electronic address: .; Pokaż więcej
Źródło:: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2024 Sep; Vol. 178, pp. 117174. Date of Electronic Publication: 2024 Aug 03.
Typ publikacji:: Journal Article
MeSH Terms:: Cisplatin*/toxicity
Cisplatin*/adverse effects
Ototoxicity*/prevention & control
Zebrafish*
Reactive Oxygen Species*/metabolism
Hearing Loss, Sensorineural*/chemically induced
Hearing Loss, Sensorineural*/drug therapy
Hearing Loss, Sensorineural*/metabolism
Hearing Loss, Sensorineural*/prevention & control
Hearing Loss, Sensorineural*/pathology
Mice, Inbred C57BL*
Apoptosis*/drug effects
Xanthones*/pharmacology
Xanthones*/therapeutic use
Hair Cells, Auditory*/drug effects
Hair Cells, Auditory*/metabolism
Hair Cells, Auditory*/pathology
Animals ; Mice ; Cell Line ; Cell Survival/drug effects ; Antioxidants/pharmacology

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 4.

Tytuł:: Combined effect of naringin and adipose tissue-derived mesenchymal stem cell on cisplatin nephrotoxicity through Sirtuin1/Nrf-2/HO-1 signaling pathway: a promising nephroprotective candidate.
Autorzy:: Amini N; Department of Physiology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. .; Persian Gulf Physiology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. .
Nejaddehbashi F; Cellular and Molecular Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Badavi M; Department of Physiology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.; Persian Gulf Physiology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Bayati V; Cellular and Molecular Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Zahra Basir; Department of Basic Sciences, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran.; Pokaż więcej
Źródło:: Cell and tissue research [Cell Tissue Res] 2024 Sep; Vol. 397 (3), pp. 193-204. Date of Electronic Publication: 2024 Jul 02.
Typ publikacji:: Journal Article
MeSH Terms:: Cisplatin*/pharmacology
Cisplatin*/adverse effects
Sirtuin 1*/metabolism
Rats, Sprague-Dawley*
NF-E2-Related Factor 2*/metabolism
Mesenchymal Stem Cells*/metabolism
Signal Transduction*/drug effects
Flavanones*/pharmacology
Flavanones*/therapeutic use
Adipose Tissue*/metabolism
Animals ; Male ; Rats ; Kidney/pathology ; Kidney/drug effects ; Kidney/metabolism ; Heme Oxygenase-1/metabolism ; Oxidative Stress/drug effects ; Heme Oxygenase (Decyclizing)/metabolism ; Mesenchymal Stem Cell Transplantation/methods

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 5.

Tytuł:: Safety and quality of cystectomy and pelvic lymph node dissection after neoadjuvant durvalumab and cisplatin/gemcitabine.
Autorzy:: Afferi L; Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland.
Spahn M; Lindenhofspital Bern, Bern, Switzerland.
Hayoz S; Competence Center of SAKK, Bern, Switzerland.
Strebel RT; Department of Urology, Kantonsspital Graubünden, Chur, Switzerland.
Rothschild SI; Department of Medical Oncology, University Hospital Basel, Basel, Switzerland.
Seifert H; Kantonsspital Baden, Baden, Switzerland.
Özdemir BC; Department of Oncology, Inselspital Bern, Bern, Switzerland.
Kiss B; Department of Urology, Inselspital Bern, Bern, Switzerland.
Maletzki P; Department of Urology, Kantonsspital Baden, Baden, Switzerland.
Engeler D; Department of Urology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Wirth G; Department of Urology, University Hospital HUG, Geneva, Switzerland.
Hadaschik B; Department of Urology, University Hospital Essen, Essen, Germany.
Lucca I; Department of Urology, University Hospital CHUV, Lausanne, Switzerland.
John H; Department of Urology, Kantonsspital Winterthur, Winterthur, Switzerland.
Sauer A; Department of Urology, Kantonsspital Aarau, Aarau, Switzerland.
Müntener M; Department of Urology, Triemlispital, Zürich, Switzerland.
Bubendorf L; Department of Pathology, University Hospital Basel, Basel, Switzerland.
Schneider M; Competence Center of SAKK, Bern, Switzerland.
Musilova J; Competence Center of SAKK, Bern, Switzerland.
Petrausch U; Onkozentrum, Zürich, Switzerland.
Cathomas R; Divison of Oncology/Hematology, Kantonsspital Graubünden, Chur, Switzerland.; Pokaż więcej
Corporate Authors:: Swiss Group for Clinical Cancer Research (SAKK)
Źródło:: BJU international [BJU Int] 2024 Sep; Vol. 134 (3), pp. 388-397. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:: Journal Article; Clinical Trial, Phase II
MeSH Terms:: Cystectomy*/methods
Lymph Node Excision*/methods
Urinary Bladder Neoplasms*/surgery
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/pathology
Neoadjuvant Therapy*
Cisplatin*/administration & dosage
Cisplatin*/therapeutic use
Gemcitabine*
Deoxycytidine*/analogs & derivatives
Deoxycytidine*/administration & dosage
Deoxycytidine*/therapeutic use
Antibodies, Monoclonal*/administration & dosage
Antibodies, Monoclonal*/therapeutic use
Antineoplastic Combined Chemotherapy Protocols*/therapeutic use
Humans ; Male ; Female ; Aged ; Middle Aged ; Pelvis ; Prospective Studies

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 6.

Tytuł:: Mitigation of cisplatin-induced hepatotoxicity by Salvia officinalis: Attenuation of oxidative damage and inflammation in rats.
Autorzy:: Gazwi HSS; Department of Agricultural Chemistry, Agriculture Faculty, Minia University, El-Minia, Egypt. Electronic address: .
Zaki AH; Department of Agricultural Chemistry, Agriculture Faculty, Minia University, El-Minia, Egypt.
Abd Allah NAR; Department of Food Science, Faculty of Agriculture, Minia University, Minia, 61519, Egypt.
Gomaa AT; Department of Agricultural Economics, Faculty of Agriculture, Minia University, 61519 Egypt.
Milošević M; Department of Biology and Ecology, Faculty of Science, University of Kragujevac, 34000, Kragujevac, Serbia.
Al-Rejaie SS; Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 55760, Riyadh, 11451, Saudi Arabia.
Mohany M; Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 55760, Riyadh, 11451, Saudi Arabia.
Yassien EE; Department of Agricultural Chemistry, Agriculture Faculty, Minia University, El-Minia, Egypt.; Pokaż więcej
Źródło:: Free radical biology & medicine [Free Radic Biol Med] 2024 Sep; Vol. 222, pp. 62-71. Date of Electronic Publication: 2024 Jun 07.
Typ publikacji:: Journal Article
MeSH Terms:: Salvia officinalis*/chemistry
Cisplatin*/adverse effects
Cisplatin*/toxicity
Oxidative Stress*/drug effects
Plant Extracts*/pharmacology
Plant Extracts*/chemistry
Chemical and Drug Induced Liver Injury*/drug therapy
Chemical and Drug Induced Liver Injury*/pathology
Chemical and Drug Induced Liver Injury*/metabolism
Chemical and Drug Induced Liver Injury*/prevention & control
Liver*/drug effects
Liver*/pathology
Liver*/metabolism
Animals ; Rats ; Male ; Inflammation/drug therapy ; Inflammation/pathology ; Inflammation/chemically induced ; Antioxidants/pharmacology ; Glutathione/metabolism

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 7.

Tytuł:: Circ_0008315 promotes tumorigenesis and cisplatin resistance and acts as a nanotherapeutic target in gastric cancer.
Autorzy:: Fei Y; Department of Gastrointestinal Surgery, The First Affiliated Hospital, Yijishan Hospital of Wannan Medical College, Wuhu, 241001, China.
Cao D; Department of Gastrointestinal Surgery, The First Affiliated Hospital, Yijishan Hospital of Wannan Medical College, Wuhu, 241001, China.
Li Y; Department of Gastrointestinal Surgery, The First Affiliated Hospital, Yijishan Hospital of Wannan Medical College, Wuhu, 241001, China.
Wang Z; Department of Gastrointestinal Surgery, The First Affiliated Hospital, Yijishan Hospital of Wannan Medical College, Wuhu, 241001, China.
Dong R; Department of Gastrointestinal Surgery, The First Affiliated Hospital, Yijishan Hospital of Wannan Medical College, Wuhu, 241001, China.
Zhu M; Department of Gastrointestinal Surgery, The First Affiliated Hospital, Yijishan Hospital of Wannan Medical College, Wuhu, 241001, China.
Gao P; Department of Gastrointestinal Surgery, The First Affiliated Hospital, Yijishan Hospital of Wannan Medical College, Wuhu, 241001, China.
Wang X; Department of Hepatobiliary Surgery, The First Affiliated Hospital, Yijishan Hospital of Wannan Medical College, Wuhu, 241001, China.
Cai J; Anhui Province Key Laboratory of Non-coding RNA Basic and Clinical Transformation, Wannan Medical College, Wuhu, 241001, China. .; Department of Oncology, The First Affiliated Hospital, Yijishan Hospital of Wannan Medical College, Wuhu, 241001, China. .
Zuo X; Department of Gastrointestinal Surgery, The First Affiliated Hospital, Yijishan Hospital of Wannan Medical College, Wuhu, 241001, China. .; Anhui Province Key Laboratory of Non-coding RNA Basic and Clinical Transformation, Wannan Medical College, Wuhu, 241001, China. .; Pokaż więcej
Źródło:: Journal of nanobiotechnology [J Nanobiotechnology] 2024 Aug 29; Vol. 22 (1), pp. 519. Date of Electronic Publication: 2024 Aug 29.
Typ publikacji:: Journal Article
MeSH Terms:: Stomach Neoplasms*/genetics
Stomach Neoplasms*/drug therapy
Stomach Neoplasms*/pathology
Cisplatin*/pharmacology
Cisplatin*/therapeutic use
RNA, Circular*/genetics
RNA, Circular*/metabolism
Drug Resistance, Neoplasm*/genetics
Humans ; Cell Line, Tumor ; Animals ; Mice ; Carcinogenesis/genetics ; Mice, Nude ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use ; Cell Proliferation/drug effects ; Female ; Male ; Gene Expression Regulation, Neoplastic/drug effects ; Tumor Microenvironment/genetics ; Epithelial-Mesenchymal Transition/genetics ; MicroRNAs/genetics ; MicroRNAs/metabolism ; Mice, Inbred BALB C

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 8.

Tytuł:: Natural products reverse cisplatin resistance in the hypoxic tumor microenvironment.
Autorzy:: Yang C; Department of Breast, Thyroid and Head-Neck Surgery, Yuebei People's Hospital of Shantou University, Shaoguan, 512099, China.
Deng X; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
Tang Y; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
Tang H; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China. Electronic address: .
Xia C; Foshan Maternity and Child Health Care Hospital, Foshan, 528000, China; School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 515150, China. Electronic address: .; Pokaż więcej
Źródło:: Cancer letters [Cancer Lett] 2024 Aug 28; Vol. 598, pp. 217116. Date of Electronic Publication: 2024 Jul 17.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Tumor Microenvironment*/drug effects
Cisplatin*/pharmacology
Cisplatin*/therapeutic use
Drug Resistance, Neoplasm*/drug effects
Biological Products*/pharmacology
Biological Products*/therapeutic use
Neoplasms*/drug therapy
Neoplasms*/pathology
Antineoplastic Agents*/pharmacology
Antineoplastic Agents*/therapeutic use
Humans ; Animals ; Cell Hypoxia/drug effects

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 9.

Tytuł:: Targeted Inhibition of Lymphovascular Invasion Formation with CREKA Peptide-Modified Silicasomes to Boost Chemotherapy in Bladder Cancer.
Autorzy:: Wu Z; Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin Medical University, Tianjin 300211, China.; CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China.; Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing 100049, China.
Li B; CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China.; Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing 100049, China.
Qie Y; Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin Medical University, Tianjin 300211, China.
Wu S; CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China.; Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing 100049, China.
Qi F; CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China.; Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing 100049, China.
Chu T; CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China.; Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing 100049, China.
Nie G; CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China.; Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing 100049, China.
Hu H; Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin Medical University, Tianjin 300211, China.; Pokaż więcej
Źródło:: Nano letters [Nano Lett] 2024 Aug 21; Vol. 24 (33), pp. 10186-10195. Date of Electronic Publication: 2024 Aug 13.
Typ publikacji:: Journal Article
MeSH Terms:: Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/pathology
Silicon Dioxide*/chemistry
Cisplatin*/pharmacology
Cisplatin*/chemistry
Cisplatin*/therapeutic use
Nanoparticles*/chemistry
Humans ; Cell Line, Tumor ; Animals ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/chemistry ; Antineoplastic Agents/therapeutic use ; Tumor Microenvironment/drug effects ; Mice ; Neoplasm Invasiveness/prevention & control ; Peptides, Cyclic/chemistry ; Peptides, Cyclic/pharmacology ; Peptides, Cyclic/therapeutic use ; Oligopeptides

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 10.

Tytuł:: β-resorcylic acid released by Limosilactobacillus reuteri protects against cisplatin-induced ovarian toxicity and infertility.
Autorzy:: Feng Y; Central Laboratory of the Medical Research Center, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang Province, China; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang Province, China; Department of Obstetrics, Affiliated Foshan Maternity & Child Healthcare Hospital, Southern Medical University, Foshan, Guangdong Province, China.
Zheng H; Central Laboratory of the Medical Research Center, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang Province, China.
Yin C; Department of Gynecology and Obstetrics, First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China.
Liang D; Department of Obstetrics and Gynecology, The First People's Hospital of Foshan, Foshan, Guangdong Province, China.
Zhang S; Department of Obstetrics and Gynecology, The First People's Hospital of Foshan, Foshan, Guangdong Province, China.
Chen J; Department of Obstetrics and Gynecology, The First People's Hospital of Foshan, Foshan, Guangdong Province, China.
Mai F; Institute of Ecological Science, School of Life Science, South China Normal University, Guangzhou, Guangdong Province, China.
Lan Z; The Second Clinical Medical College, Southern Medical University, Guangzhou, Guangdong Province, China.
Zhu M; The Second Clinical Medical College, Southern Medical University, Guangzhou, Guangdong Province, China.
Mai Z; Department of Obstetrics and Gynecology, The First People's Hospital of Foshan, Foshan, Guangdong Province, China.
Shen S; UNSW Microbiome Research Centre, St George and Sutherland Clinical Campuses, UNSW Sydney, Sydney, NSW, Australia.
Jayawardana T; UNSW Microbiome Research Centre, St George and Sutherland Clinical Campuses, UNSW Sydney, Sydney, NSW, Australia.
Wu R; School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China.
Tang W; Central Laboratory of the Medical Research Center, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang Province, China.
Zhang R; Department of Gynecology and Obstetrics, First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China.
He X; Department of Gynecology and Obstetrics, First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China.
Zheng S; Health Medical Center, The First People's Hospital of Foshan, Foshan, Guangdong Province, China.
Hu Q; Institute of Translational Medicine, The First People's Hospital of Foshan, Foshan, Guangdong Province, China.
Han Y; Department of Obstetrics and Gynecology, The First People's Hospital of Foshan, Foshan, Guangdong Province, China.
Yang Y; Mater Research Institute, The University of Queensland, Woolloongabba, QLD 4102, Australia; Institute for Molecular Bioscience, The University of Queensland, St Lucia, QLD 4072, Australia.
Gong S; School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China.
Wang Z; Institute of Ecological Science, School of Life Science, South China Normal University, Guangzhou, Guangdong Province, China.
El-Omar EM; UNSW Microbiome Research Centre, St George and Sutherland Clinical Campuses, UNSW Sydney, Sydney, NSW, Australia.
Luo W; Institute of Translational Medicine, The First People's Hospital of Foshan, Foshan, Guangdong Province, China.
Chen X; Central Laboratory of the Medical Research Center, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang Province, China; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang Province, China. Electronic address: .
Chen G; Institute of Translational Medicine, The First People's Hospital of Foshan, Foshan, Guangdong Province, China. Electronic address: .
Li P; UNSW Microbiome Research Centre, St George and Sutherland Clinical Campuses, UNSW Sydney, Sydney, NSW, Australia. Electronic address: .
Chen X; Central Laboratory of the Medical Research Center, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang Province, China; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang Province, China. Electronic address: chenx_.; Pokaż więcej
Źródło:: Cell reports. Medicine [Cell Rep Med] 2024 Aug 20; Vol. 5 (8), pp. 101678. Date of Electronic Publication: 2024 Aug 02.
Typ publikacji:: Journal Article
MeSH Terms:: Cisplatin*/adverse effects
Cisplatin*/toxicity
Limosilactobacillus reuteri*
Primary Ovarian Insufficiency*/chemically induced
Primary Ovarian Insufficiency*/pathology
Ovary*/drug effects
Ovary*/pathology
Ovary*/metabolism
Female ; Animals ; Mice ; Gastrointestinal Microbiome/drug effects ; Apoptosis/drug effects ; Fecal Microbiota Transplantation ; Oocytes/drug effects ; Oocytes/metabolism ; Mice, Inbred C57BL ; Antineoplastic Agents/toxicity ; Antineoplastic Agents/adverse effects ; Granulosa Cells/drug effects ; Granulosa Cells/metabolism ; Disease Models, Animal ; Infertility

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 11.

Tytuł:: Mitochondria-Targeted Multifunctional Nanoprodrugs by Inhibiting Metabolic Reprogramming for Combating Cisplatin-Resistant Lung Cancer.
Autorzy:: Lu H; Jilin University School of Pharmaceutical Sciences, Changchun 130021, China.
Tong W; Department of Otolaryngology Head and Neck Surgery, The Second Hospital of Jilin University, Changchun 130041, China.
Jiang M; Jilin University School of Pharmaceutical Sciences, Changchun 130021, China.
Liu H; Jilin University School of Pharmaceutical Sciences, Changchun 130021, China.
Meng C; Jilin University School of Pharmaceutical Sciences, Changchun 130021, China.
Wang K; Jilin University School of Pharmaceutical Sciences, Changchun 130021, China.
Mu X; Scientific Research Center, China-Japan Union Hospital of Jilin University, Changchun 130033, China.; Pokaż więcej
Źródło:: ACS nano [ACS Nano] 2024 Aug 13; Vol. 18 (32), pp. 21156-21170. Date of Electronic Publication: 2024 Aug 01.
Typ publikacji:: Journal Article
MeSH Terms:: Cisplatin*/pharmacology
Cisplatin*/chemistry
Mitochondria*/drug effects
Mitochondria*/metabolism
Antineoplastic Agents*/pharmacology
Antineoplastic Agents*/chemistry
Lung Neoplasms*/drug therapy
Lung Neoplasms*/metabolism
Lung Neoplasms*/pathology
Drug Resistance, Neoplasm*/drug effects
Prodrugs*/pharmacology
Prodrugs*/chemistry
Humans ; Nanoparticles/chemistry ; Animals ; Mice ; Drug Delivery Systems ; Cell Proliferation/drug effects ; Drug Screening Assays, Antitumor ; Cell Line, Tumor ; Metabolic Reprogramming

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 12.

Tytuł:: Artemisinin pre-treatment fore cisplatin dosage enhances high grade urothelial carcinoma treatment in male albino mice via reverse gene expression modulation of FGFR3, HRAS, P53 and KDM6A.
Autorzy:: Botrous S; Department of Genetics, Faculty of Agriculture, Alexandria University, Alexandria, Egypt. .
Elmaghraby A; Department of Nucleic Acid Research, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications, Alexandria, Egypt.
Achy SE; Department of Surgical Pathology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Mustafa Y; Department of Genetics, Faculty of Agriculture, Alexandria University, Alexandria, Egypt.
Abdel-Rahman S; Department of Nucleic Acid Research, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications, Alexandria, Egypt. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Aug 08; Vol. 24 (1), pp. 971. Date of Electronic Publication: 2024 Aug 08.
Typ publikacji:: Journal Article
MeSH Terms:: Cisplatin*/pharmacology
Cisplatin*/therapeutic use
Artemisinins*/pharmacology
Artemisinins*/therapeutic use
Receptor, Fibroblast Growth Factor, Type 3*/genetics
Receptor, Fibroblast Growth Factor, Type 3*/metabolism
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/genetics
Urinary Bladder Neoplasms*/pathology
Tumor Suppressor Protein p53*/genetics
Tumor Suppressor Protein p53*/metabolism
Gene Expression Regulation, Neoplastic*/drug effects
Histone Demethylases*/metabolism
Histone Demethylases*/genetics
Animals ; Male ; Mice ; Proto-Oncogene Proteins p21(ras)/genetics ; Humans ; Disease Models, Animal ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 13.

Tytuł:: Cabazitaxel as a promising therapy for cisplatin-resistant bladder cancer: a preliminary study.
Autorzy:: Joshi A; Karkinos Healthcare Pvt Ltd, 21st floor, Rupa Renaissance, D33, Turbhe MIDC road, Navi Mumbai, Maharashtra, 400705, India.; Karkinos Foundation, Mumbai, Maharashtra, 400086, India.
Ghosh A; Karkinos Healthcare Pvt Ltd, 21st floor, Rupa Renaissance, D33, Turbhe MIDC road, Navi Mumbai, Maharashtra, 400705, India.; Karkinos Foundation, Mumbai, Maharashtra, 400086, India.
Rai P; Karkinos Healthcare Pvt Ltd, 21st floor, Rupa Renaissance, D33, Turbhe MIDC road, Navi Mumbai, Maharashtra, 400705, India.; Karkinos Foundation, Mumbai, Maharashtra, 400086, India.
Tilwani S; Karkinos Healthcare Pvt Ltd, 21st floor, Rupa Renaissance, D33, Turbhe MIDC road, Navi Mumbai, Maharashtra, 400705, India.; Karkinos Foundation, Mumbai, Maharashtra, 400086, India.
Ramachandran V; Karkinos Healthcare Pvt Ltd, 21st floor, Rupa Renaissance, D33, Turbhe MIDC road, Navi Mumbai, Maharashtra, 400705, India.; Karkinos Foundation, Mumbai, Maharashtra, 400086, India.
Prabhash K; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, 400012, India.; Homi Bhabha National Institute, Training School Complex, Anushakti Nagar, Mumbai, Maharashtra, 400094, India.
Amin M; Department of Pathology and Laboratory Medicine, University of Tennessee Health Science, Memphis, TN, USA.
Kumar P; Karkinos Healthcare Pvt Ltd, 21st floor, Rupa Renaissance, D33, Turbhe MIDC road, Navi Mumbai, Maharashtra, 400705, India. .; Karkinos Foundation, Mumbai, Maharashtra, 400086, India. .; Centre of Excellence for Cancer-Gangwal School of Medical Sciences and Technology, Indian Institute of Technology Kanpur, Kanpur, Uttar Pradesh, 208016, India. .; Pokaż więcej
Źródło:: Medical oncology (Northwood, London, England) [Med Oncol] 2024 Aug 06; Vol. 41 (9), pp. 219. Date of Electronic Publication: 2024 Aug 06.
Typ publikacji:: Journal Article
MeSH Terms:: Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/pathology
Drug Resistance, Neoplasm*/drug effects
Cisplatin*/pharmacology
Cisplatin*/therapeutic use
Taxoids*/pharmacology
Taxoids*/therapeutic use
Antineoplastic Agents*/pharmacology
Antineoplastic Agents*/therapeutic use
Humans ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cell Movement/drug effects

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 14.

Tytuł:: Identification and validation of genes associated with prognosis of cisplatin-resistant ovarian cancer.
Autorzy:: Liu D; Department of Obstetrics and Gynecology, The First Hospital of Lanzhou University, Lanzhou, China. .
Li R; The First Clinical Medical College, Lanzhou University, Lanzhou, China.
Wang Y; The First Clinical Medical College, Lanzhou University, Lanzhou, China.
Li D; The First Clinical Medical College, Lanzhou University, Lanzhou, China.
Li L; The First Clinical Medical College, Lanzhou University, Lanzhou, China.; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Aug 05; Vol. 24 (1), pp. 508. Date of Electronic Publication: 2024 Aug 05.
Typ publikacji:: Journal Article
MeSH Terms:: Cisplatin*/therapeutic use
Cisplatin*/pharmacology
Ovarian Neoplasms*/genetics
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/mortality
Ovarian Neoplasms*/pathology
Drug Resistance, Neoplasm*/genetics
Gene Expression Regulation, Neoplastic*
Humans ; Female ; Prognosis ; Biomarkers, Tumor/genetics ; Gene Expression Profiling ; Cell Line, Tumor ; Antineoplastic Agents/therapeutic use ; Antineoplastic Agents/pharmacology ; Transcriptome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Treatment options for cisplatin-ineligible patients with locally advanced head and neck squamous cell carcinoma: a systematic review.
Autorzy:: Michelon I; Department of Medicine, Catholic University of Pelotas, Pelotas, Brazil.
Nachtigal GC; Department of Internal Medicine, Federal University of Pelotas Teaching Hospital (EBSERH), Pelotas, Brazil.
Dacoregio MI; Department of Medicine, University of Centro Oeste, Guarapuava, Brazil.
Moraes ACBK; Department of Surgery, Faculty of Medicine, Catholic University of Pelotas, Pelotas, Brazil.; Graduate Program in Dentistry, School of Dentistry, Federal University of Pelotas, Pelotas, RS, 96015560, Brazil.
Moraes M; Department of Medicine, Federal University of Pelotas, Pelotas, Brazil.
Piva LS; Department of Medicine, Federal University of Pelotas, Pelotas, Brazil.
da Costa CT; Graduate Program in Dentistry, School of Dentistry, Federal University of Pelotas, Pelotas, RS, 96015560, Brazil.
Lund RG; Graduate Program in Dentistry, School of Dentistry, Federal University of Pelotas, Pelotas, RS, 96015560, Brazil.
Michelon D; Graduate Program in Dentistry, School of Dentistry, Federal University of Pelotas, Pelotas, RS, 96015560, Brazil. .; Pokaż więcej
Źródło:: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2024 Aug 02; Vol. 150 (8), pp. 379. Date of Electronic Publication: 2024 Aug 02.
Typ publikacji:: Systematic Review; Journal Article
MeSH Terms:: Cisplatin*/administration & dosage
Cisplatin*/therapeutic use
Squamous Cell Carcinoma of Head and Neck*/drug therapy
Squamous Cell Carcinoma of Head and Neck*/pathology
Squamous Cell Carcinoma of Head and Neck*/therapy
Squamous Cell Carcinoma of Head and Neck*/mortality
Head and Neck Neoplasms*/drug therapy
Head and Neck Neoplasms*/pathology
Head and Neck Neoplasms*/therapy
Head and Neck Neoplasms*/mortality
Humans ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Chemoradiotherapy/methods ; Cetuximab/therapeutic use ; Cetuximab/administration & dosage ; Carboplatin/administration & dosage ; Antineoplastic Agents/therapeutic use

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 16.

Tytuł:: The role of genetic variants in the prediction of hearing loss due to cisplatin chemoradiotherapy.
Autorzy:: Duinkerken CW; Department of Otolaryngology and Head and Neck Surgery, Leiden University Medical Centre, Leiden, the Netherlands.; Department of Head and Neck Surgery, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
Chiodo S; Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada.
Hueniken K; Department of Biostatistics, University Health Network, Toronto, Canada.
Hauptmann M; Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany.
Jóźwiak K; Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany.
Cheng D; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada.
Hope A; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada.
Liu G; Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada.
Zuur CL; Department of Otolaryngology and Head and Neck Surgery, Leiden University Medical Centre, Leiden, the Netherlands.; Department of Head and Neck Surgery, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2024 Aug; Vol. 13 (16), pp. e7465.
Typ publikacji:: Journal Article
MeSH Terms:: Cisplatin*/adverse effects
Cisplatin*/therapeutic use
Polymorphism, Single Nucleotide*
Chemoradiotherapy*/adverse effects
Chemoradiotherapy*/methods
Humans ; Male ; Female ; Middle Aged ; Retrospective Studies ; Aged ; Head and Neck Neoplasms/genetics ; Head and Neck Neoplasms/therapy ; Head and Neck Neoplasms/radiotherapy ; Head and Neck Neoplasms/drug therapy ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/therapeutic use ; Adult ; Hearing Loss/genetics ; Hearing Loss/chemically induced ; Squamous Cell Carcinoma of Head and Neck/genetics ; Squamous Cell Carcinoma of Head and Neck/therapy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Enhancing chemotherapeutic efficacy: Niosome-encapsulated Dox-Cis with MUC-1 aptamer.
Autorzy:: Barlas FB; Institute for Technical Chemistry, Leibniz University Hannover, Hannover, Germany.; Institue of Nanotechnology and Biotechnology, İstanbul University-Cerrahpaşa, İstanbul, Turkey.
Olceroglu B; Institue of Nanotechnology and Biotechnology, İstanbul University-Cerrahpaşa, İstanbul, Turkey.
Ag Seleci D; Institute for Particle Technology (iPAT), Technische Universität Braunschweig, Braunschweig, Germany.
Gumus ZP; Central Research Test and Analysis Laboratory Application and Research Center, Ege University, Izmir, Turkey.
Siyah P; Department of Biochemistry, School of Pharmacy, Bahçeşehir University, Istanbul, Turkey.
Dabbek M; Institute for Technical Chemistry, Leibniz University Hannover, Hannover, Germany.
Garnweitne G; Institute for Particle Technology (iPAT), Technische Universität Braunschweig, Braunschweig, Germany.
Stahl F; Institute for Technical Chemistry, Leibniz University Hannover, Hannover, Germany.
Scheper T; Institute for Technical Chemistry, Leibniz University Hannover, Hannover, Germany.
Timur S; Central Research Test and Analysis Laboratory Application and Research Center, Ege University, Izmir, Turkey.; Department of Biochemistry, Faculty of Science, Ege University, Izmir, Turkey.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2024 Aug; Vol. 13 (15), pp. e70079.
Typ publikacji:: Journal Article
MeSH Terms:: Doxorubicin*/pharmacology
Doxorubicin*/chemistry
Mucin-1*/metabolism
Mucin-1*/chemistry
Liposomes*/chemistry
Cisplatin*/pharmacology
Cisplatin*/chemistry
Aptamers, Nucleotide*/chemistry
Aptamers, Nucleotide*/pharmacology
Cell Survival*/drug effects
Humans ; Apoptosis/drug effects ; Cell Line, Tumor ; HeLa Cells ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/chemistry ; Drug Compounding/methods

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Effects of ginsenoside Rh2 on cisplatin-induced nephrotoxicity in renal tubular epithelial cells by inhibiting endoplasmic reticulum stress.
Autorzy:: Wang L; School of Life Sciences, Jilin University, Changchun, China.; School of Traditional Chinese Medicine, Jilin Agricultural Science and Technology University, Changchun, China.
Hao X; Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, China.
Li X; Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, China.
Li Q; Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, China.
Fang X; Key Laboratory for Molecular Enzymology and Engineering of Ministry of Education, School of Life Sciences, Jilin University, Changchun, China.; Pokaż więcej
Źródło:: Journal of biochemical and molecular toxicology [J Biochem Mol Toxicol] 2024 Aug; Vol. 38 (8), pp. e23768.
Typ publikacji:: Journal Article
MeSH Terms:: Ginsenosides*/pharmacology
Cisplatin*/adverse effects
Cisplatin*/toxicity
Endoplasmic Reticulum Stress*/drug effects
Epithelial Cells*/drug effects
Epithelial Cells*/metabolism
Kidney Tubules*/drug effects
Kidney Tubules*/pathology
Kidney Tubules*/metabolism
Acute Kidney Injury*/chemically induced
Acute Kidney Injury*/pathology
Acute Kidney Injury*/metabolism
Acute Kidney Injury*/prevention & control
Acute Kidney Injury*/drug therapy
Animals ; Mice ; Humans ; Male ; Cell Line ; Apoptosis/drug effects ; Mice, Inbred C57BL

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 19.

Tytuł:: Co-administration of either curcumin or resveratrol with cisplatin treatment decreases hepatotoxicity in rats via anti-inflammatory and oxidative stress-apoptotic pathways.
Autorzy:: Ramadan OI; Department of Dental Basic Sciences, Faculty of Dentistry, Applied Science Private University, Amman, Jordan.; Histology Department, Damietta Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
S Ali L; Department of Basic Medical Science, Faculty of Dentistry, Al-Ahliyya Amman University, Amman, Jordan.; Department of Medical Physiology, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
M Abd-Allah F; Histology Department, Damietta Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
E A Ereba R; Department of Pharmacology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
S Humeda H; Department of Physiology, Faculty of Medicine, Alzaiem AlAzhari University, Khartoum North, Sudan.; Physiology Department, General Medicine Practice Program, Batterjee Medical College, Aseer, Saudi Arabia.
A Damanhory A; Department of Biochemistry, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.; Department of Biochemistry, General Medicine Practice Program, Batterjee Medical College, Jeddah, Saudi Arabia.
E Moustafa A; Medical Biochemistry Department, Damietta Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
M Younes A; Anatomy and Embryology Department, Damietta Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
M Y Awad M; Anatomy and Embryology Department, Damietta Faculty of Medicine, Al-Azhar University, Cairo, Egypt.; Anatomy Department, General Medicine Practice Program, Batterjee Medical Collage, Aseer, Saudi Arabia.
A A Omar N; Anatomy Department, General Medicine Practice Program, Batterjee Medical Collage, Aseer, Saudi Arabia.; Department of Anatomy, Faculty of Medicine, Sohag University, Sohag, Egypt.; Pokaż więcej
Źródło:: PeerJ [PeerJ] 2024 Jul 22; Vol. 12, pp. e17687. Date of Electronic Publication: 2024 Jul 22 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Resveratrol*/pharmacology
Resveratrol*/administration & dosage
Cisplatin*/toxicity
Cisplatin*/administration & dosage
Curcumin*/pharmacology
Curcumin*/administration & dosage
Oxidative Stress*/drug effects
Apoptosis*/drug effects
Chemical and Drug Induced Liver Injury*/pathology
Chemical and Drug Induced Liver Injury*/drug therapy
Chemical and Drug Induced Liver Injury*/metabolism
Chemical and Drug Induced Liver Injury*/prevention & control
Chemical and Drug Induced Liver Injury*/etiology
Animals ; Male ; Rats ; Antineoplastic Agents/administration & dosage ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/toxicity ; Liver/drug effects ; Liver/metabolism ; Liver/pathology ; Antioxidants/pharmacology ; Antioxidants/administration & dosage ; Stilbenes/administration & dosage ; Stilbenes/pharmacology ; Stilbenes/therapeutic use ; Anti-Inflammatory Agents/pharmacology ; Anti-Inflammatory Agents/administration & dosage ; Rats, Wistar

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 20.

Tytuł:: Targeting ferroptosis in ovarian cancer: Novel strategies to overcome chemotherapy resistance.
Autorzy:: Kapper C; Experimental Gynaecology, Obstetrics and Gynaecological Endocrinology, Johannes Kepler University Linz, Altenberger Strasse 69, 4040 Linz, Austria.
Oppelt P; Experimental Gynaecology, Obstetrics and Gynaecological Endocrinology, Johannes Kepler University Linz, Altenberger Strasse 69, 4040 Linz, Austria; Department for Gynaecology, Obstetrics and Gynaecological Endocrinology, Kepler University Hospital, Johannes Kepler University Linz, Austria.
Arbeithuber B; Experimental Gynaecology, Obstetrics and Gynaecological Endocrinology, Johannes Kepler University Linz, Altenberger Strasse 69, 4040 Linz, Austria.
Gyunesh AA; Experimental Gynaecology, Obstetrics and Gynaecological Endocrinology, Johannes Kepler University Linz, Altenberger Strasse 69, 4040 Linz, Austria.
Vilusic I; Experimental Gynaecology, Obstetrics and Gynaecological Endocrinology, Johannes Kepler University Linz, Altenberger Strasse 69, 4040 Linz, Austria.
Stelzl P; Department for Gynaecology, Obstetrics and Gynaecological Endocrinology, Kepler University Hospital, Johannes Kepler University Linz, Austria.
Rezk-Füreder M; Experimental Gynaecology, Obstetrics and Gynaecological Endocrinology, Johannes Kepler University Linz, Altenberger Strasse 69, 4040 Linz, Austria. Electronic address: .; Pokaż więcej
Źródło:: Life sciences [Life Sci] 2024 Jul 15; Vol. 349, pp. 122720. Date of Electronic Publication: 2024 May 16.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Ferroptosis*/drug effects
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/pathology
Ovarian Neoplasms*/metabolism
Drug Resistance, Neoplasm*
Antineoplastic Agents*/pharmacology
Antineoplastic Agents*/therapeutic use
Cisplatin*/pharmacology
Cisplatin*/therapeutic use
Humans ; Female ; Animals

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Informacja

Wyszukujesz frazę ""Cisplatin"" wg kryterium: Temat